Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on November 11, 2004

Arteriosclerosis, Thrombosis, and Vascular Biology. 2004
Published online before print November 11, 2004, doi: 10.1161/01.ATV.0000150415.18759.36
A more recent version of this article appeared on January 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/1/198    most recent
01.ATV.0000150415.18759.36v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cederholm, A.
Right arrow Articles by Frostegård, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cederholm, A.
Right arrow Articles by Frostegård, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Lupus

Submitted on May 13, 2004
Accepted on October 28, 2004

Decreased Binding of Annexin V to Endothelial Cells. A Potential Mechanism in Atherothrombosis of Patients With Systemic Lupus Erythematosus

Anna Cederholm *; Elisabet Svenungsson ; Kerstin Jensen-Urstad ; Christina Trollmo ; Ann-Kristin Ulfgren ; Jesper Swedenborg ; Guo-Zhong Fei ; and Johan Frostegård

From the Department of Medicine (A.C., G.-Z.F., J.F.), CIM and CME, Karolinska University Hospital, Huddinge; the Department of Medicine (E.S., C.T., A.-K.U.), Rheumatology Unit and CMM, Karolinska University Hospital, Solna; the Department of Clinical Physiology (K.J.-U.), Södersjukhuset; Department of Surgery (J.S.), Karolinska University Hospital, Huddinge; and the Karolinska Institutet (A.C., E.S., K.J.-U., C.T., A.-K.U., J.S., G.-Z.F., J.F.), Stockholm, Sweden.

* To whom correspondence should be addressed. E-mail: anna.cederholm{at}medhs.ki.se.

Objective--The cause of the exceedingly high risk of atherothrombosis in Systemic Lupus Erythematosus (SLE) is not clear but antiphospholipid antibodies (aPL) and potentially antithrombotic annexin V have been implicated.

Methods and Results--Twenty-six women (52±8.2 years) with SLE and a history of cardiovascular disease (CVD) (SLE cases) were compared with 26 women with SLE but no CVD (SLE controls) and 26 healthy women (population controls). Common carotid intima-media thickness (IMT) was determined by B-mode ultrasound as a surrogate measure of atherosclerosis. Annexin V binding to human umbilical vein endothelial cells (HUVECs) as determined by flow cytometry after 24-hour culture with plasma was decreased when plasma from SLE cases was used (SLE cases versus population controls: P=0.002; SLE cases versus SLE controls P=0.02). Antibodies against cardiolipin were among IgG antibodies causing decreased binding. There was a positive association between annexin V binding and IMT (R=0.73; P<0.001) among SLE cases. Immunohistochemical analysis revealed presence of annexin V in all human atherosclerotic plaques tested, especially at sites prone to rupture.

Conclusions--Decreased annexin V binding to endothelium caused by autoantibodies may represent a novel mechanism of atherothrombosis. We hypothesize that even though annexin V may promote plaque growth at some disease stages, it may also stabilize plaque.


Key words: systemic lupus erythematosus • atherothrombosis • atherosclerosis • annexin V • antibodies




This article has been cited by other articles:


Home page
LupusHome page
J. Rand, X. Wu, A. Quinn, and D. Taatjes
Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome
Lupus, October 1, 2008; 17(10): 922 - 930.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
J. Su, X. Hua, H. Concha, E. Svenungsson, A. Cederholm, and J. Frostegard
Natural antibodies against phosphorylcholine as potential protective factors in SLE
Rheumatology, August 1, 2008; 47(8): 1144 - 1150.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
J Frostegard
Systemic lupus erythematosus and cardiovascular disease
Lupus, May 1, 2008; 17(5): 364 - 367.
[Abstract] [PDF]


Home page
BloodHome page
J. M. Malleier, O. Oskolkova, V. Bochkov, I. Jerabek, B. Sokolikova, T. Perkmann, J. Breuss, B. R. Binder, and M. Geiger
Regulation of protein C inhibitor (PCI) activity by specific oxidized and negatively charged phospholipids
Blood, June 1, 2007; 109(11): 4769 - 4776.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. de Laat, X.-X. Wu, M. van Lummel, R. H. W. M. Derksen, P. G. de Groot, and J. H. Rand
Correlation between antiphospholipid antibodies that recognize domain I of {beta}2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5
Blood, February 15, 2007; 109(4): 1490 - 1494.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M McMahon, J Grossman, W Chen, and B H Hahn
Inflammation and the pathogenesis of atherosclerosis in systemic lupus erythematosus
Lupus, November 1, 2006; 15(11_suppl): 59 - 69.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. Monceau, Y. Belikova, G. Kratassiouk, E. Robidel, F. Russo-Marie, and D. Charlemagne
Myocyte apoptosis during acute myocardial infarction in rats is related to early sarcolemmal translocation of annexin A5 in border zone
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H965 - H971.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
S I van Leuven, J J. Kastelein, D P D'Cruz, G R Hughes, and E S Stroes
Atherogenesis in rheumatology
Lupus, March 1, 2006; 15(3): 117 - 121.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Frostegard
Atherosclerosis in Patients With Autoimmune Disorders
Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1776 - 1785.
[Abstract] [Full Text] [PDF]